Trial record 3 of 4 for:
EHVA
A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04844775 |
|
Recruitment Status :
Active, not recruiting
First Posted : April 14, 2021
Last Update Posted : January 3, 2024
|
Sponsor:
ANRS, Emerging Infectious Diseases
Collaborators:
Medical Research Council
Henri Mondor University Hospital
Chelsea and Westminster Hospital, UK
EuroVacc Foundation
European Commission
Swiss Government
University College London Hospitals
Imperial College London
Recherche Clinique Paris Descartes Necker Cochin Sainte Anne
Information provided by (Responsible Party):
ANRS, Emerging Infectious Diseases
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | September 30, 2024 |
| Estimated Study Completion Date : | September 30, 2024 |